Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant versus ondansetron for prevention of postoperative nausea and vomiting after middle ear surgery
PACTR202603505186889Phase 3Completed
- Sponsor
- Saad Eldesoky Elzayat
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative nausea and vomiting (PONV) comparing Aprepitant arm with Ondansetron arm (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting. Started Aug 2024; status: completed.
02
Drugs
aprepitantondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on PACTR202603505186889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202603505186889.